Literature DB >> 18682532

Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP.

Krishan Johansson-Haque1, Elanchelian Palanichamy, Sam Okret.   

Abstract

Glucocorticoids (GCs) are known to inhibit mitogen-activated protein kinase (MAPK) signaling. This has been suggested to involve induced expression of MAPK-phosphatase 1 (DUSP1), which dephosphorylates and inactivates MAPKs. However, the mechanism for the transcriptional activation by GCs of DUSP1 or the identification of a GC-responsive region of the gene has so far not been described. To identify GC receptor (GR) binding to the human DUSP1 promoter in vivo, we used a chromatin immunoprecipitation (ChIP) assay and found GR to bind to a region approximately -1.4 kb upstream of the transcription start site. Using promoter deletion constructs, we identified a GC-responsive region between position -1266 and -1380 bp of the DUSP1 promoter. However, no direct binding of GR to this GC-responsive region was detected in an electrophoretic mobility shift assay (EMSA). Instead, we identified binding of CCAAT/enhancer-binding protein beta (C/EBPbeta) to a region between -1311 and -1304 bp of the DUSP1 promoter by EMSA and ChIP. Furthermore, mutation of the C/EBP binding site resulted in a dramatic loss of GC-inducible reporter gene expression, demonstrating the GC responsiveness of the DUSP1 gene to be located to a binding site for C/EBP in the DUSP1 promoter. Also, given that a GR mutant (GR(LS7)), incapable of transactivating through GC-responsive elements, still was able to bind to the DUSP1 gene in vivo and induce DUSP1 mRNA expression following treatment with GCs suggests the mode of GC activation to be mediated by a tethering mechanism involving the GR and the DUSP1 promoter-bound C/EBPbeta.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682532     DOI: 10.1677/JME-08-0015

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  27 in total

Review 1.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Structural Modeling of GR Interactions with the SWI/SNF Chromatin Remodeling Complex and C/EBP.

Authors:  Serena Muratcioglu; Diego M Presman; John R Pooley; Lars Grøntved; Gordon L Hager; Ruth Nussinov; Ozlem Keskin; Attila Gursoy
Journal:  Biophys J       Date:  2015-08-13       Impact factor: 4.033

3.  In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).

Authors:  Harminder S Dua; Ahmad Muneer Otri; Andrew Hopkinson; Imran Mohammed
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 4.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

5.  Rapamycin induces mitogen-activated protein (MAP) kinase phosphatase-1 (MKP-1) expression through activation of protein kinase B and mitogen-activated protein kinase kinase pathways.

Authors:  Ruchi Rastogi; Zhongliang Jiang; Nisar Ahmad; Rita Rosati; Yusen Liu; Laurent Beuret; Robert Monks; Jean Charron; Morris J Birnbaum; Lobelia Samavati
Journal:  J Biol Chem       Date:  2013-10-14       Impact factor: 5.157

Review 6.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

7.  Dual-specificity phosphatase 1 as a pharmacogenetic modifier of inhaled steroid response among asthmatic patients.

Authors:  Ying Jin; Donglei Hu; Edward L Peterson; Celeste Eng; Albert M Levin; Karen Wells; Kenneth Beckman; Rajesh Kumar; Max A Seibold; Gloria Karungi; Amanda Zoratti; John Gaggin; Janis Campbell; Joshua Galanter; Rocío Chapela; José R Rodríguez-Santana; H Geoffrey Watson; Kelley Meade; Michael Lenoir; William Rodríguez-Cintrón; Pedro C Avila; David E Lanfear; Esteban G Burchard; L Keoki Williams
Journal:  J Allergy Clin Immunol       Date:  2010-07-31       Impact factor: 10.793

8.  Profiling molecular changes induced by hydrogen treatment of lung allografts prior to procurement.

Authors:  Yugo Tanaka; Norihisa Shigemura; Tomohiro Kawamura; Kentaro Noda; Kumiko Isse; Donna Beer Stolz; Timothy R Billiar; Yoshiya Toyoda; Christian A Bermudez; James Lyons-Weiler; Atsunori Nakao
Journal:  Biochem Biophys Res Commun       Date:  2012-08-07       Impact factor: 3.575

9.  Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells.

Authors:  Megan E Cavet; Karen L Harrington; Keith W Ward; Jin-Zhong Zhang
Journal:  Mol Vis       Date:  2010-09-02       Impact factor: 2.367

10.  Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence.

Authors:  Carmen R Tchen; Joana R S Martins; Nasren Paktiawal; Roberta Perelli; Jeremy Saklatvala; Andrew R Clark
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.